132 related articles for article (PubMed ID: 38679969)
1. Efficacy of SARS-CoV-2 Vaccine Doses in Allogeneic Hemopoietic Stem Cell Recipients: Concerns.
Daungsupawong H; Wiwanitkit V
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1111. PubMed ID: 38679969
[No Abstract] [Full Text] [Related]
2. Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT.
Redjoul R; Le Bouter A; Parinet V; Fourati S; Maury S
Lancet Haematol; 2021 Oct; 8(10):e681-e683. PubMed ID: 34487683
[No Abstract] [Full Text] [Related]
3. Efficacy of SARS-CoV-2 Vaccine Doses in Allogeneic Hemopoietic Stem Cell Recipients: A Systematic Review and Meta-Analysis.
Rubin M; Suelzer E; Ulschmid C; Thapa B; Szabo A; Bilal Abid M
Asian Pac J Cancer Prev; 2024 Feb; 25(2):393-399. PubMed ID: 38415523
[TBL] [Abstract][Full Text] [Related]
4. Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response-a prospective, single-arm study.
Barkhordar M; Chahardouli B; Biglari A; Ahmadvand M; Bahri T; Alaeddini F; Sharifi Aliabadi L; Noorani SS; Bagheri Amiri F; Biglari M; Shemshadi MR; Ghavamzadeh A; Vaezi M
Front Immunol; 2023; 14():1169666. PubMed ID: 37153556
[TBL] [Abstract][Full Text] [Related]
5. Specific immune response to mRNA vaccines against COVID-19 in patients receiving allogeneic stem cell transplantation for myeloid malignancy was altered by immunosuppressive therapy.
Macková J; Hainz P; Kryštofová J; Roubalová K; Šťastná-Marková M; Vaníková Š; Musil J; Vydra J; Němečková Š
Leuk Res; 2023 Jul; 130():107314. PubMed ID: 37216792
[TBL] [Abstract][Full Text] [Related]
6. Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysis.
Sharifi Aliabadi L; Azari M; Taherian MR; Barkhordar M; Abbas SAM; Azari M; Ahmadvand M; Salehi Z; Rouzbahani S; Vaezi M
Virol J; 2024 May; 21(1):103. PubMed ID: 38702752
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Mittal A; Solera JT; Ferreira VH; Kothari S; Kimura M; Pasic I; Mattsson JI; Humar A; Kulasingam V; Ierullo M; Kumar D; Hosseini-Moghaddam SM
Transplant Cell Ther; 2023 Nov; 29(11):706.e1-706.e7. PubMed ID: 37582470
[TBL] [Abstract][Full Text] [Related]
8. Is a third SARS-CoV-2 vaccine dose efficient in allogeneic haematopoietic cell transplant recipients?
Spyridonidis A
Br J Haematol; 2023 Apr; 201(1):9-10. PubMed ID: 36477621
[TBL] [Abstract][Full Text] [Related]
9. Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.
Al Jalali V; Scherzer S; Zeitlinger M
Clin Microbiol Infect; 2021 Oct; 27(10):1529-1530. PubMed ID: 34192576
[No Abstract] [Full Text] [Related]
10. Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients.
Kimura M; Ferreira VH; Kothari S; Pasic I; Mattsson JI; Kulasingam V; Humar A; Mah A; Delisle JS; Ierullo M; Majchrzak-Kita B; Kumar D; Hosseini-Moghaddam SM
Transplant Cell Ther; 2022 Oct; 28(10):706.e1-706.e10. PubMed ID: 35914727
[TBL] [Abstract][Full Text] [Related]
11. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
[TBL] [Abstract][Full Text] [Related]
12. Metabolic disorders, COVID-19 and vaccine-breakthrough infections.
Stefan N
Nat Rev Endocrinol; 2022 Feb; 18(2):75-76. PubMed ID: 34873287
[TBL] [Abstract][Full Text] [Related]
13. Antibody response after second BNT162b2 dose in allogeneic HSCT recipients.
Redjoul R; Le Bouter A; Beckerich F; Fourati S; Maury S
Lancet; 2021 Jul; 398(10297):298-299. PubMed ID: 34270933
[No Abstract] [Full Text] [Related]
14. SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group.
Piñana JL; López-Corral L; Martino R; Montoro J; Vazquez L; Pérez A; Martin-Martin G; Facal-Malvar A; Ferrer E; Pascual MJ; Sanz-Linares G; Gago B; Sanchez-Salinas A; Villalon L; Conesa-Garcia V; Olave MT; López-Jimenez J; Marcos-Corrales S; García-Blázquez M; Garcia-Gutiérrez V; Hernández-Rivas JÁ; Saus A; Espigado I; Alonso C; Hernani R; Solano C; Ferrer-Lores B; Guerreiro M; Ruiz-García M; Muñoz-Bellido JL; Navarro D; Cedillo A; Sureda A;
Am J Hematol; 2022 Jan; 97(1):30-42. PubMed ID: 34695229
[TBL] [Abstract][Full Text] [Related]
15. The variants of SARS-CoV-2 and the challenges of vaccines.
Han X; Ye Q
J Med Virol; 2022 Apr; 94(4):1366-1372. PubMed ID: 34890492
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus disease 2019 vaccination in transplant recipients.
Eberhardt CS; Balletto E; Cornberg M; Mikulska M
Curr Opin Infect Dis; 2021 Aug; 34(4):275-287. PubMed ID: 34074880
[TBL] [Abstract][Full Text] [Related]
17. Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation.
Sherman AC; Cheng CA; Swank Z; Zhou G; Li X; Issa NC; Walt DR; Baden LR; Soiffer RJ
Transplant Cell Ther; 2023 May; 29(5):337.e1-337.e5. PubMed ID: 36736784
[TBL] [Abstract][Full Text] [Related]
18. Non-COVID-19 hospitalisation as a negative control outcome in COVID-19 vaccine effectiveness studies.
Poukka E; Auranen K; Baum U
Lancet Infect Dis; 2024 May; 24(5):e275. PubMed ID: 38402890
[No Abstract] [Full Text] [Related]
19. Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients.
Harrington P; Doores KJ; Saha C; Saunders J; Child F; Dillon R; Saglam S; Raj K; McLornan D; Avenoso D; Kordasti S; O'Reilly A; Espehana A; Lechmere T; Khan H; Malim MH; Harrison C; Mehra V; de Lavallade H
Cancer Cell; 2021 Nov; 39(11):1448-1449. PubMed ID: 34717827
[No Abstract] [Full Text] [Related]
20. COVID-19 vaccine breakthrough infections.
Gupta RK; Topol EJ
Science; 2021 Dec; 374(6575):1561-1562. PubMed ID: 34941414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
